α-Synuclein病理和线粒体功能障碍:帕金森病的有毒伙伴
Yakum B Mingo1, Martha L Escobar Galvis2, Michael X Henderson1
1Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI 49503, United States of America.
Neurobiology of disease
|March 29, 2025
概括
帕金森病涉及α-synuclein病理和线粒体功能障碍. 这篇评论探讨了它们的相互作用,表明线粒体问题可能是帕金森病中常见的神经退行途径.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 病理学 病理学 病理学
背景情况:
- 帕金森病 (PD) 的特点是α-synuclein Lewy病理和线粒体功能障碍.
- 在PD病变发生过程中,α-synuclein和线粒体健康之间的相互作用仍然不完全理解.
研究的目的:
- 审查神经元中α-synuclein和线粒体平衡的生理作用.
- 讨论与这些功能相关的PD病理缺陷.
- 在PD中探索α-synuclein和线粒体之间的相互作用.
主要方法:
- 关于α-synuclein,线粒体功能和帕金森病的研究文献综述.
- 对与PD病变发生相关的细胞生物学和遗传研究的分析.
主要成果:
- 在PD中,功能失调的线粒体被发现在Lewy体内.
- 阿尔法-同核素可以直接损害线粒体功能.
- 破坏线粒体平衡的遗传或环境因素与PD病例有关.
结论:
- 线粒体功能障碍可能代表帕金森病中常见的神经退行性途径,由各种侮辱引发.
- 了解α-synuclein-mitochondria相互作用对于开发PD新型疾病修饰疗法至关重要.
更多相关视频
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
6.3K
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
2.4K
相关概念视频
Neural Regulation
34.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.8K
Lysosomal Hydrolases
3.5K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.5K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Alzheimer Disease ll: Pathophysiology
42
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
42
Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Parkinson Disease ll: Pathophysiology
34
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
34
